The approval of Tennessee’s Medicaid 1115 Research and Demonstration waiver by the Centers for Medicare and Medicaid Services (CMS) today is the latest in a wave of approvals in the last few months of waivers that all weaken the state programs.
The U.S. Senate passed legislation tonight aimed at improving access to clinical trials for communities of color and decreasing health disparities.
A companion to a House bill introduced in the Senate today aims to improve access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more Americans.
The U.S. House of Representatives is expected to pass legislation today aimed at improving access to clinical trials for communities of color and decreasing health disparities.
More than a dozen patient groups representing millions of Americans with serious and chronic health conditions are urging the U.S. District Court for the Southern District of New York to preserve protections in the Affordable Care Act (ACA) for lesbian, gay, bisexual, transgender and queer (LGBTQ) patients receiving health care
A new bill introduced in the U.S. House of Representatives today aims to improve access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more Americans.
Cancer patients and survivors continue to experience potentially serious health care delays during the pandemic, and tomorrow leadership across Oklahoma will shine a light on the disparities affecting Native Americans’ cancer outcomes.
Tobacco is the leading cause of preventable death nationwide and is linked to at least 13 types of cancer. Reducing use of this deadly product is critical to our mission to end suffering and death from this disease. Given the industry’s known targeting of people with lower incomes, Black communities, American Indians, youth, and LGBTQ individuals, tobacco control efforts are also crucial to reduce cancer disparities in this country.
The American Cancer Society Cancer Action Network (ACS CAN) today released a report detailing the costs of treating cancer, specifically out-of-pocket costs typical cancer patients face. The report found U.S. cancer patients in 2018 spent $5.6 billion in out-of-pocket costs for cancer treatment
La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN por sus siglas en inglés) publicó hoy un informe que detalla los costos del tratamiento de cáncer, específicamente los gastos de bolsillo que enfrentan los típicos pacientes de cáncer.